Janux Therapeutics, Inc.

NASDAQ:JANX

23.98 (USD) • At close September 5, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2025 Q22025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q1
Operating Activities:
Net Income -33.858-23.508-20.216-28.059-5.959-14.76-11.758-11.568-17.508-17.459-16.065-16.696-16.888-13.41-13.416-10.766-6.206-2.284-1.655-1.256-2.46-1.413
Depreciation & Amortization 0.5410.5190.5120.510.5060.5320.5310.50.4710.4530.4030.2490.1080.0810.0640.0270.0130.0090.0090.0010.0010.002
Deferred Income Tax 00000000000000-13.4890000000
Stock Based Compensation 10.9610.7026.25115.3875.7575.6254.4834.5485.5015.4734.2054.5964.4443.9582.9442.5661.2770.1230.040.0280.0020.002
Change In Working Capital 3.75-0.516-0.34511.799-7.352-4.447-1.096-3.081-1.677-0.70.836-0.7956.362-2.127-0.0152.398-1.2567.715-0.0230.1440.322-0.054
Accounts Receivables 0007.5-6.981-0.519000.75-0.750.5-0.50000.37507.625-8000
Change In Inventory 00000000-0.750000000.2260-0.2530000
Change In Accounts Payables 1.113-1.6371.5591.175-0.694-0.4560.3270.228-0.171-0.1070.223-0.6340.857-0.74-0.4822.584-0.310.347-0.1980.0450.236-0.069
Other Working Capital 2.6371.121-1.90411.6540.323-3.472-1.423-3.309-1.5060.1570.1130.3395.505-1.3870.467-0.787-0.946-0.0048.1750.0990.0860.015
Other Non Cash Items -5.206-4.221-2.927-1.868-2.973-1.787-2.061-2.108-1.841-1.678-1.292-0.768-0.099-0.02413.431-0.079-0.032-7.8317.8020.0451.3540.587
Operating Cash Flow -23.813-17.024-16.725-2.231-10.021-14.837-9.901-11.709-15.054-13.911-11.913-13.414-6.073-11.522-10.481-5.854-6.2045.563-1.629-1.083-0.781-0.876
Investing Activities:
Investments In Property Plant And Equipment -0.473-0.371-0.042-0.025-0.095-0.197-0.515-0.47-0.58-0.285-2.056-2.52-0.898-0.971-1.173-0.077-0.079-0.1530000
Acquisitions Net 000000-11.63860.981-18.4548.4550-22.283-9.9370-120.3730000000
Purchases Of Investments -92.685-371.291-24.032-32.466-235.54-178.539-33.112-135.981-76.546-71.705-86.048-94.467-68.813-45.061-103.501-227.607-142.51800000
Sales Maturities Of Investments 94.7231.275845.16544.756544.75759563.2586.5116.7578.7577.111222.145000000
Other Investing Activites 00000011.638-60.98118.454-8.455022.2839.93732.039120.37322.145-142.51800000
Investing Cash Flow 1.562-340.39233.92612.674-190.885-113.73611.123-61.45117.874-8.74-1.60419.7639.03931.0687.326-205.539-142.597-0.1530000
Financing Activities:
Debt Repayment 0000000000000000000011.5
Common Stock Issued 0.9540.554378.2081.649-0.455320.5140.83156.530.5281.58000.3080.00156.565-0.843329.65757.5460000
Common Stock Repurchased 0000000000000000000000
Dividends Paid 0000000000000000000000
Other Financing Activities 000001.65700.0790.5281.580.19100.3080.0010.1640329.65757.5464.553-0.06690.004
Financing Cash Flow 0.9540.554386.651.6492.765322.1710.83156.6090.5281.580.19100.3080.0010.164-0.843329.65757.5464.553-0.0335.51.504
Other Information:
Effect Of Forex Changes On Cash 0000000000000000000000
Net Change In Cash -21.297-356.862403.85112.092-198.141193.5982.053-16.5513.348-21.071-13.3266.3493.27419.547-2.991-212.236180.85662.9562.924-1.1164.7190.628
Cash At End Of Period 53.26273.743431.42127.5714.662212.80320.02117.96834.51931.17152.24265.56859.21955.94536.39839.389251.62570.7697.8134.8896.0051.286